Home/Filings/4/0001129240-03-000009
4//SEC Filing

DR DAUGHTON JAMES 4

Accession 0001129240-03-000009

CIK 0000724910other

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 5:05 PM ET

Size

10.6 KB

Accession

0001129240-03-000009

Insider Transaction Report

Form 4
Period: 2003-08-14
DR DAUGHTON JAMES
DirectorChief Technology Officer
Transactions
  • Sale

    Common Stock

    2003-08-15$18.50/sh2,000$37,000365,300 total
  • Sale

    Common Stock

    2003-08-18$19.25/sh1,000$19,250364,300 total
  • Sale

    Common Stock

    2003-08-14$18.00/sh5,600$100,800367,300 total
Holdings
  • Incentive Stock Option

    Exercise: $6.08From: 2001-07-26Exp: 2011-07-26Common Stock (22,600 underlying)
    57,600
  • Incentive Stock Option

    Exercise: $0.86From: 2003-01-01Exp: 2005-01-01Common Stock (35,000 underlying)
    35,000
Footnotes (2)
  • [F1]Includes shares owned jointly by Dr. Daughton and his spouse.
  • [F2]Vesting in four equal installments with the first installment vesting 7/26/2001.

Issuer

NVE CORP /NEW/

CIK 0000724910

Entity typeother
IncorporatedMN

Related Parties

1
  • filerCIK 0001129240

Filing Metadata

Form type
4
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 5:05 PM ET
Size
10.6 KB